Sun Pharmaceutical Industries Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	524715	NSE Symbol:	SUNPHARMA	P/E :	157.55
ISIN Demat:	INE044A01036	Div & Yield %:	0.83	EPS :	12.27
Book Value:	93.24	Market Cap (Rs. Cr.):	463,815.44	Face Value :	1

Date	Headline
15-Jul-26	Sun Pharma receives approval to market semaglutide injection in South Africa
11-Jul-26	Sun Pharmaceuticals Industries announces board meeting date
12-Jun-26	Sun Pharmaceuticals Industries schedules AGM
23-May-26	Board of Sun Pharmaceuticals Industries recommends final dividend
12-May-26	Sun Pharmaceuticals Industries to declare Quarterly Results
07-May-26	Sun Pharmaceutical receives credit ratings from CRISIL and ICRA
27-Apr-26	Sun Pharmaceuticals enters definitive agreement to acquire Organon
24-Apr-26	Sun Pharma incorporates subsidiary in U.S.
21-Mar-26	Sun Pharma launches semaglutide injection under brand names Noveltreat and Sematrinity in India
31-Jan-26	Board of Sun Pharmaceuticals Industries recommends interim dividend

Company Snapshot